FDA NDC Directory · JSON-LD · Markdown

TOUJEO

NDC 0024-5869 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin glargine
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA206538
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (300 U/mL)
Marketing started20150215
Package count2

External sources

Source: openFDA. Public-domain (CC0).